Genome-wide analysis of DNA methylation and expression of microRNAs in breast cancer cells

International Journal of Molecular Sciences

Volumn 13, Issue 7, 2012, Pages 8259-8272

  Morita, Sumiyo ^a   Takahashi, Ryou u ^b   Yamashita, Riu ^c   Toyoda, Atsushi ^d   Horii, Takuro ^a   Kimura, Mika ^a   Fujiyama, Asao ^d   Nakai, Kenta ^e   Tajima, Shoji ^f   Matoba, Ryo ^g   Ochiya, Takahiro ^b   Hatada, Izuho ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF GENETICS   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f OSAKA UNIVERSITY   (Japan)

^g DNA CHIP RESEARCH INC   (Japan)

Author keywords

Cancer; DNA methylation; MicroRNA

Indexed keywords

MICRORNA; UNTRANSLATED RNA; TRANSCRIPTOME;

ARTICLE; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE SILENCING; GENOME ANALYSIS; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NEXT GENERATION SEQUENCING; PROMOTER REGION; PSEUDOGENE; RNA TRANSCRIPTION; SEQUENCE ANALYSIS; BREAST TUMOR; DNA SEQUENCE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; MCF 7 CELL LINE; METABOLISM; TRANSCRIPTION INITIATION SITE;

BREAST NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; MCF-7 CELLS; MICRORNAS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION INITIATION SITE; TRANSCRIPTOME;

EID: 84864326005     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13078259     Document Type: Article

References (28)

1. Ohgane, J.; Aikawa, J.; Ogura, A.; Hattori, N.; Ogawa, T.; Shiota, K. Analysis of CpG islands of trophoblast giant cells by restriction landmark genomic scanning. Dev. Genet. 1998, 22, 132-140.
2. Song, F.; Smith, J.F.; Kimura, M.T.; Morrow, A.D.; Matsuyama, T.; Nagase, H.; Held, W.A. Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc. Natl. Acad. Sci. USA 2005, 102, 3336-3341.
3. Klose, R.J.; Bird, A.P. Genomic DNA methylation: The mark and its mediators. Trends Biochem. Sci. 2006, 31, 89-97.
4. Razin, A.; Webb, C.; Szyf, M.; Yisraeli, J.; Rosenthal, A.; Naveh-Many, T.; Sciaky-Gallili, N.; Cedar, H. Variations in DNA methylation during mouse cell differentiation in vivo and in vitro. Proc. Natl. Acad. Sci.USA 1984, 81, 2275-2279.
5. Bird, A.P.; Wolffe, A.P. Methylation-induced repression-Belts, braces, and chromatin. Cell 1999, 99, 451-454.
6. Feinberg, A.P.; Tycko, B. The history of cancer epigenetics. Nat. Rev. Cancer 2004, 4, 143-153.
7. Herman, J.G. Baylin, S.B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 2003, 349, 2042-2054.
8. Zhang, B.; Pan, X.; Cobb, G.P.; Anderson, T.A. microRNAs as oncogenes and tumor suppressors. Dev. Biol. 2007, 302, 1-12.
9. Hatada, I.; Hayashizaki, Y.; Hirotsune, S.; Komatsubara, H.; Mukai, T. A genomic scanning method for higher organisms using restriction sites as landmarks. Proc. Natl. Acad. Sci. USA 1991, 88, 9523-9527.
10. Hatada, I.; Sugama, T.; Mukai, T. A new imprinted gene cloned by a methylation-sensitive genome scanning method. Nucleic. Acids. Res. 1993, 21, 5577-5582.
11. Yoshikawa, H.; Matsubara, K.; Qian, G.S.; Jackson, P.; Groopman, J.D.; Manning, J.E.; Harris, C.C.; Herman, J.G. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat. Genet. 2001, 28, 29-35.
12. Yu, L.; Liu, C.; Vandeusen, J.; Becknell, B.; Dai, Z.; Wu, Y.Z.; Raval, A.; Liu, T.H.; Ding, W.; Mao, C.; et al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat. Genet. 2005, 37, 265-274.
13. Hatada, I. An Omics Perspective on Cancer Research; Cho, W.C.S., Ed.; Springer: Dordrecht, The Netherlands, 2010; pp. 51-68.
14. Brenet, F.; Moh, M.; Funk, P.; Feierstein, E.; Viale, A.J.; Socci, N.D.; Scandura, J.M. DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS One 2011, 6, doi:10.1371/journal.pone.0014524.
15. Ohki, I.; Shimotake, N.; Fujita, N.; Jee, J.; Ikegami, T.; Nakao, M.; Shirakawa, M. Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell 2001, 105, 487-497.
16. Fairchild, C.R.; Ivy, S.P.; Kao-Shan, C.S.; Whang-Peng, J.; Rosen, N.; Israel, M.A.; Melera, P.W.; Cowan, K.H.; Goldsmith, M.E. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res. 1987, 47, 5141-5148.
17. David, G.L.; Yegnasubramanian, S.; Kumar, A.; Marchi, V.L.; de Marzo, A.M.; Lin, X.; Nelson, W.G. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: Changes in chromatin structure induced by treatment with 5-Aza-cytidine. Cancer Biol. Ther. 2004, 3, 540-548.
18. Graff, J.R.; Herman, J.G.; Lapidus, R.G.; Chopra, H.; Xu, R.; Jarrard, D.F.; Isaacs, W.B.; Pitha, P.M.; Davidson, N.E.; Baylin, S.B. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 1995, 55, 5195-5199.
19. Ai, L.; Kim, W.J.; Demircan, B.; Dyer, L.M.; Bray, K.J.; Skehan, R.R.; Massoll, N.A.; Brown, K.D. The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer. Carcinogenesis 2008, 29, 510-518.
20. Ozsolak, F.; Poling, L.L.; Wang, Z.; Liu, H.; Liu, X.S.; Roeder, R.G.; Zhang, X.; Song, J.S.; Fisher, D.E. Chromatin structure analyses identify miRNA promoters. Genes. Dev. 2008, 22, 3172-3183.
21. Shimono, Y.; Zabala, M.; Cho, R.W.; Lobo, N.; Dalerba, P.; Qian, D.; Diehn, M.; Liu, H.; Panula, S.P.; Chiao, E.; et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009, 138, 592-603.
22. Gregory, P.A.; Bert, A.G.; Paterson, E.L.; Barry, S.C.; Tsykin, A.; Farshid, G.; Vadas, M.A.; Khew-Goodall, Y.; Goodall, G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10, 593-601.
23. Tryndyak, V.P.; Beland, F.A.; Pogribny, I.P. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int. J. Cancer 2010, 126, 2575-2783.
24. Hellman, A.; Chess, A. Gene body-specific methylation on the active X chromosome. Science 2007, 315, 1141-1143.
25. Wu, H.; Coskun, V.; Tao, J.; Xie, W.; Ge, W.; Yoshikawa, K.; Li, E.; Zhang, Y.; Sun, Y.E. Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes. Science 2010, 329, 444-448.
26. Selvakumar, T.; Gjidoda, A.; Hovde, S.L.; Henry, R.W. Regulation of human RNA polymerase III transcription by DNMT1 and DNMT3a DNA methyltransferases. J. Biol. Chem. 2012, 287, 7039-7050.
27. Marshall, L.; White, R.J. Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat. Rev. Cancer 2008, 8, 911-914.
28. Bird, A.P. CpG-rich islands and the function of DNA methylation. Nature 1986, 321, 209-213.